@Article{Obojski2003,
journal="Central European Journal of\ Immunology",
issn="1426-3912",
volume="28",
number="1",
year="2003",
title="Anti-inflammatory drugs in asthma therapy",
abstract=" Abstract   Asthma is a chronic inflammatory disease. Pharmacologic management of asthma comprises long-term treatment to suppress the airway inflammation and quick-relief treatment to provide prompt reversal of acute bronchoconstriction and its accompanying symptoms. Anti-inflammatory agents are of crucial importance in asthma therapy. The most potent and effective medications used for long-term treatment of asthma are inhaled corticosteroids. Other medications, like: cromones, leukotriene antagonists and theophylline also show, but much less, anti-inflammatory activity. They can be used alternatively to inhaled corticosteroids in patients with mild persistent asthma but they are less effective. The add-on therapy with those medications should be considered if asthma control is not achieved with initial inhaled corticosteroid therapy. The combination treatment with long-acting \β 2 -agonists and inhaled corticosteroids has become the treatment of choice for the majority of asthmatic patients and nowadays constitutes the new \”gold standard\” of asthma therapy.",
author="Obojski, Andrzej
and Kraus-Filarska, Maria",
pages="29--35",
url="https://www.termedia.pl/Anti-inflammatory-drugs-in-asthma-therapy,10,1484,1,1.html"
}